Schedule 13G ownership disclosure
PETROS PHARMACEUTICALS INC
Common Stock, $0.0001 par value · CUSIP: 71678J209
Event date: 2025-02-17
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Iroquois Capital Management, LLC
Shares: 902,084.00 · Class: 3.6%
- Richard Abbe
Shares: 2,527,084.00 · Class: 9.99%
- Kimberly Page
Shares: 902,084.00 · Class: 3.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000930413-25-000708
- Form type
- SCHEDULE 13G
- Filer
- Iroquois Capital Management, LLC
- CIK
- CIK 1481867
- Filed
- Feb 26, 2025
- Reporting period
- Feb 17, 2025
- Description
- Schedule 13G beneficial ownership